vx has been researched along with Encephalopathy, Toxic in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (75.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Bezdekova, D; Hrabinova, M; Jost, P; Jun, D; Kobrlova, T; Korabecny, J; Muckova, L; Pulkrabkova, L; Sorf, A; Soukup, O | 1 |
Aggarwal, N; Ashani, Y; Goldsmith, M; Leader, H; Reiter, G; Seeger, T; Sussman, JL; Tawfik, DS; Thiermann, H; Worek, F | 1 |
Bajgar, J | 1 |
Clark, MG; Finneran, K; Hilmas, CJ; Poole, MJ; Williams, PT | 1 |
McDonough, JH; Shih, TM; Skovira, JW | 1 |
Newmark, J | 1 |
Eyer, P; Szinicz, L; Thiermann, H; Worek, F | 1 |
Allon, N; Bloch-Shilderman, E; Egoz, I; Gilat, E; Grauer, E; Rabinovitz, I; Raveh, L; Weissman, BA | 1 |
1 review(s) available for vx and Encephalopathy, Toxic
Article | Year |
---|---|
Therapy for nerve agent poisoning.
Topics: Antidotes; Atropine; Chemical Warfare Agents; Humans; Neurotoxicity Syndromes; Neurotoxins; Organophosphate Poisoning; Organophosphates; Organothiophosphorus Compounds; Pralidoxime Compounds; Pyridostigmine Bromide; Sarin; Soman | 2004 |
7 other study(ies) available for vx and Encephalopathy, Toxic
Article | Year |
---|---|
Differentiated SH-SY5Y neuroblastoma cells as a model for evaluation of nerve agent-associated neurotoxicity.
Topics: Acetylcholinesterase; Antineoplastic Agents; Cell Line, Tumor; Humans; Nerve Agents; Neuroblastoma; Neurotoxicity Syndromes | 2023 |
Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study.
Topics: Acetylcholinesterase; Animals; Antidotes; Brain; Catalysis; Chemical Warfare Agents; Cholinesterase Inhibitors; Drug Administration Schedule; Erythrocytes; Guinea Pigs; Hydrolysis; Male; Mutation; Neurotoxicity Syndromes; Organothiophosphorus Compounds; Phosphoric Triester Hydrolases; Protein Engineering; Recombinant Proteins; Time Factors | 2014 |
Protective effect of reversible cholinesterase inhibitors (tacrine, pyridostigmine) and eqbuche against VX poisoning and brain acetylcholinesterase inhibition in rats.
Topics: Animals; Brain; Chemical Warfare Agents; Cholinesterase Inhibitors; Female; Neurotoxicity Syndromes; Organothiophosphorus Compounds; Pyridostigmine Bromide; Rats; Rats, Wistar; Tacrine | 2008 |
Galantamine is a novel post-exposure therapeutic against lethal VX challenge.
Topics: Acetylcholinesterase; Animals; Antidotes; Atropine; Cholinesterase Inhibitors; Cholinesterase Reactivators; Diaphragm; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroencephalography; Erythrocytes; Galantamine; Guinea Pigs; Male; Muscle Fatigue; Muscle Tonus; Neurotoxicity Syndromes; Organothiophosphorus Compounds; Paralysis; Phrenic Nerve; Pralidoxime Compounds; Seizures; Time Factors | 2009 |
Effects of 4-pyridine aldoxime on nerve agent-inhibited acetylcholinesterase activity in guinea pigs.
Topics: Acetylcholinesterase; Animals; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterase Reactivators; Dose-Response Relationship, Drug; Drug Interactions; Guinea Pigs; Longevity; Male; Neurotoxicity Syndromes; Organophosphorus Compounds; Organothiophosphorus Compounds; Oximes; Salivation; Sarin; Seizures; Tears | 2009 |
Simulation of cholinesterase status at different scenarios of nerve agent exposure.
Topics: Animals; Chemical Warfare Agents; Cholinesterase Reactivators; Cholinesterases; Computer Simulation; Dose-Response Relationship, Drug; Humans; Models, Biological; Neurotoxicity Syndromes; Organothiophosphorus Compounds; Oximes; Premedication; Time Factors | 2007 |
Subchronic exposure to low-doses of the nerve agent VX: physiological, behavioral, histopathological and neurochemical studies.
Topics: Animals; Behavior, Animal; Blood Cell Count; Blood Chemical Analysis; Blotting, Western; Body Weight; Brain; Brain Chemistry; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterases; Chronic Disease; Drug Implants; Male; Maze Learning; Muscarinic Agonists; Neurotoxicity Syndromes; Organothiophosphorus Compounds; Oxotremorine; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Subcellular Fractions | 2008 |